Persistence of newly detected human papillomavirus type 31 infection, stratified by variant lineage

International Journal of Cancer

Volumn 132, Issue 3, 2013, Pages 549-555

  Xi, Long Fu ^a,b   Schiffman, Mark ^c   Koutsky, Laura A ^b   He, Zhonghu ^d   Winer, Rachel L ^b   Hulbert, Ayaka ^a   Lee, Shu Kuang ^b   Ke, Yang ^d   Kiviat, Nancy B ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

human papillomavirus; persistence; variants

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 31; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT; VIRAL CLEARANCE;

ADULT; AFRICAN AMERICANS; DISEASE PROGRESSION; DNA, VIRAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC VARIATION; HUMAN PAPILLOMAVIRUS 31; HUMANS; PAPILLOMAVIRUS INFECTIONS; VIRAL LOAD; YOUNG ADULT;

EID: 84870236874     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27689     Document Type: Article

References (31)

1. Bernard HU, Calleja-Macias IE, Dunn ST,. Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer 2006; 118: 1071-6.
2. Calleja-Macias IE, Kalantari M, Huh J, et al. Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants. Virology 2004; 319: 315-23.
3. Calleja-Macias IE, Villa LL, Prado JC, et al. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J Virol 2005; 79: 13630-40.
4. Raiol T, Wyant PS, de Amorim RM, et al. Genetic variability and phylogeny of the high-risk HPV-31, -33, -35, -52, and -58 in central Brazil. J Med Virol 2009; 81: 685-92.
5. Cornut G, Gagnon S, Hankins C, et al. Polymorphism of the capsid L1 gene of human papillomavirus types 31, 33, and 35. J Med Virol 2010; 82: 1168-78.
6. Chagas BS, Batista MV, Guimaraes V, et al. New variants of E6 and E7 oncogenes of human papillomavirus type 31 identified in Northeastern Brazil. Gynecol Oncol 2011; 123: 284-8.
7. Safaeian M, van Doorslaer K, Schiffman M, et al. Lack of heterogeneity of HPV16 E7 sequence compared with HPV31 and HPV73 may be related to its unique carcinogenic properties. Arch Virol 2010; 155: 367-70.
8. Gagnon S, Hankins C, Tremblay C, et al. Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of HIV-seropositive and HIV-seronegative women at risk for HIV infection. J Med Virol 2005; 75: 213-21.
9. Cento V, Rahmatalla N, Ciccozzi M, et al. Intratype variations of HPV 31 and 58 in Italian women with abnormal cervical cytology. J Med Virol 2011; 83: 1752-61.
10. Chen Z, Schiffman M, Herrero R, et al. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One 2011; 6: e20183.
11. Xi L, Schiffman M, Koutsky L, et al. Association of human papillomavirus type 31 variants with risk of cervical intraepithelial neoplasia grades 2-3. Int J Cancer 2012. DOI:10.1002/ijc.27520.
12. Schlecht NF, Kulaga S, Robitaille J, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001; 286: 3106-14.
13. Kjaer SK, van den Brule AJ, Paull G, et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 2002; 325: 572.
14. Ylitalo N, Josefsson A, Melbye M, et al. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. Cancer Res 2000; 60: 6027-32.
15. Ho GY, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87: 1365-71.
16. Remmink AJ, Walboomers JM, Helmerhorst TJ, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995; 61: 306-11.
17. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999; 354: 20-5.
18. Rodriguez AC, Schiffman M, Herrero R, et al. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst 2008; 100: 513-7.
19. Chen HC, Schiffman M, Lin CY, et al. Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. J Natl Cancer Inst 2011; 103: 1387-96.
20. Munoz N, Hernandez-Suarez G, Mendez F, et al. Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women. Br J Cancer 2009; 100: 1184-90.
21. Kjaer SK, Frederiksen K, Munk C, et al. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst 2010; 102: 1478-88.
22. Xi LF, Kiviat NB, Hildesheim A, et al. Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J Natl Cancer Inst 2006; 98: 1045-52.
23. Schiffman M, Adrianza ME,. ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants. Acta Cytol 2000; 44: 726-42.
24. Goldsborough MD, DiSilvestre D, Temple GF, et al. Nucleotide sequence of human papillomavirus type 31: a cervical neoplasia-associated virus. Virology 1989; 171: 306-11.
25. Fen J, Yoshinouchi M, Nakamura K, et al. Eradication of HPV post-surgical treatments, its correlation with specific types, types of surgery and the physical status. Oncol Rep 2004; 12: 375-9.
26. Sarian LO, Derchain SF, Pittal Dda R, et al. Human papillomavirus detection by hybrid capture II and residual or recurrent high-grade squamous cervical intraepithelial neoplasia after large loop excision of the transformation zone (LLETZ). Tumori 2005; 91: 188-92.
27. Londesborough P, Ho L, Terry G, et al. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 1996; 69: 364-8.
28. Bontkes HJ, van Duin M, de Gruijl TD, et al. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer 1998; 78: 166-71.
29. Villa LL, Sichero L, Rahal P, et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 2000; 81: 2959-68.
30. Schlecht NF, Burk RD, Palefsky JM, et al. Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women. J Gen Virol 2005; 86: 2709-20.
31. Schiffman M, Rodriguez AC, Chen Z, et al. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res 2010; 70: 3159-69.